4.8 Article

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

Related references

Note: Only part of the references are listed.
Article Hematology

Loss of ASXL1 triggers an apoptotic response in human hematopoietic stem and progenitor cells

Susan Hilgendorf et al.

EXPERIMENTAL HEMATOLOGY (2016)

Article Medicine, Research & Experimental

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

MYC regulates the antitumor immune response through CD47 and PD-L1

Stephanie C. Casey et al.

SCIENCE (2016)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Medicine, General & Internal

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Sagar Lonial et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Immunology

Tumor-Associated Macrophages: From Mechanisms to Therapy

Roy Noy et al.

IMMUNITY (2014)

Article Biochemistry & Molecular Biology

NCBI GEO: archive for functional genomics data sets-update

Tanya Barrett et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

High-Resolution Transcriptome of Human Macrophages

Marc Beyer et al.

PLOS ONE (2012)

Article Multidisciplinary Sciences

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Immunology

Signal regulatory protein alpha (SIRPα)/CD47 interaction and function

A. Neil Barclay

CURRENT OPINION IN IMMUNOLOGY (2009)

Review Immunology

Signal regulatory proteins in the immune system

EM van Beek et al.

JOURNAL OF IMMUNOLOGY (2005)

Review Cell Biology

Integrin-associated protein (CD47) and its ligands

EJ Brown et al.

TRENDS IN CELL BIOLOGY (2001)